Mangoceuticals Inc (MGRX) USD0.0001

Sell:$1.73Buy:$1.75$0.04 (2.25%)

Prices delayed by at least 15 minutes
Sell:$1.73
Buy:$1.75
Change:$0.04 (2.25%)
Prices delayed by at least 15 minutes
Sell:$1.73
Buy:$1.75
Change:$0.04 (2.25%)
Prices delayed by at least 15 minutes

Company Information

About this company

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Key people

Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Antonios Isaac
President, Director
Eugene M. Johnston
Chief Financial Officer
Amanda Hammer
Chief Operating Officer
Lorraine Dalessio
Independent Director
Alex P. Hamilton
Independent Director
Kenny Myers
Independent Director
Click to see more

Key facts

  • EPIC
    MGRX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    US56270V2051
  • Market cap
    $19.53m
  • Employees
    -
  • Shares in issue
    7.85m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.